13 insiders reported 40 Form 4 transactions for OnKure Therapeutics, Inc. (OKUR) over the past 18 months (most recent 2026-09-23). Recent activity: Leverone Jason A. (Chief Financial Officer) Sell 302 shares, Saccomano Nicholas A (President and CEO) Sell 87 shares, Saccomano Nicholas A (President and CEO) Sell 86 shares, Leverone Jason A. (Chief Financial Officer) Sell 303 shares, Leverone Jason A. (Chief Financial Officer) Sell 301 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-23 | Leverone Jason A. | Chief Financial Officer | Sell | 302 | $898 |
| 2026-09-23 | Saccomano Nicholas A | President and CEO | Sell | 87 | $259 |
| 2026-06-24 | Saccomano Nicholas A | President and CEO | Sell | 86 | $378 |
| 2026-06-24 | Leverone Jason A. | Chief Financial Officer | Sell | 303 | $1,333 |
| 2026-03-24 | Leverone Jason A. | Chief Financial Officer | Sell | 301 | $1,252 |
| 2026-03-24 | Saccomano Nicholas A | President and CEO | Sell | 86 | $358 |
| 2026-01-02 | Mathers Edward T | Director | Buy | 3,911 | $0 |
| 2026-01-02 | Manke Isaac | Director | Buy | 5,258 | $0 |
| 2025-12-23 | Saccomano Nicholas A | President and CEO | Sell | 87 | $258 |
| 2025-12-23 | Leverone Jason A. | Chief Financial Officer | Sell | 302 | $897 |
| 2025-10-02 | Mathers Edward T | Director | Buy | 4,125 | $0 |
| 2025-10-02 | Manke Isaac | Director | Buy | 5,545 | $0 |
| 2025-09-24 | Leverone Jason A. | Chief Financial Officer | Sell | 303 | $794 |
| 2025-09-24 | Saccomano Nicholas A | President and CEO | Sell | 88 | $231 |
| 2025-07-02 | Manke Isaac | Director | Buy | 6,311 | $0 |
| 2025-07-02 | Mathers Edward T | Director | Buy | 4,694 | $0 |
| 2025-06-25 | Leverone Jason A. | Chief Financial Officer | Sell | 303 | $721 |
| 2025-06-25 | Saccomano Nicholas A | President and CEO | Sell | 88 | $209 |
| 2025-05-19 | Hove Anders D | 10% Owner | Buy | 270,270 | $500,000 |
| 2025-05-19 | Chen Bihua | Insider | Sell | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Global Healthcare Master Fund, LP | Insider | Sell | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Private Healthcare Fund III LP | Insider | Sell | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Private Healthcare Fund IV LP | Insider | Sell | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Private Healthcare Fund V LP | Insider | Sell | 1.8M | $3.4M |
| 2025-05-19 | Cormorant Asset Management, LP | Insider | Sell | 1.8M | $3.4M |
Source: SEC Form 4 filings · as of 2026-09-23